Joann Lindenfeld Selected Research

Joann Lindenfeld Research Topics

Disease

23	Heart Failure 01/2023 - 04/2004
3	Hemorrhage 11/2023 - 09/2019
3	Congenital Heart Defects (Congenital Heart Defect) 11/2023 - 11/2018
2	Cardiogenic Shock 11/2023 - 01/2022
2	Ischemia 11/2023 - 05/2012
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 12/2019
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2013 - 08/2009
2	Neoplasms (Cancer) 09/2010 - 05/2010
1	Cardiac Arrhythmias (Arrythmia) 11/2023
1	Stroke (Strokes) 11/2023
1	Hyperkalemia 11/2022
1	Pulmonary Edema 01/2022
1	COVID-19 09/2021
1	Primary Graft Dysfunction 09/2021
1	Cardiomyopathies (Cardiomyopathy) 12/2013
1	Left Ventricular Dysfunction 03/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2012
1	Frailty 03/2012
1	Hiccup (Hiccups) 12/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2011
1	Urinary Retention 10/2011
1	Drug-Related Side Effects and Adverse Reactions 02/2011
1	Heart Diseases (Heart Disease) 09/2010
1	Hypertension (High Blood Pressure) 05/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010
1	Chronic Renal Insufficiency 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Coronary Disease (Coronary Heart Disease) 07/2009
1	Systolic Heart Failure 11/2008
1	Coronary Stenosis (Coronary Artery Stenosis) 06/2008
1	Anemia 03/2005
1	Chest Pain (Chest Pains) 03/2005

Drug/Important Bio-Agent (IBA)

3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 03/2005
3	Mineralocorticoid Receptor AntagonistsIBA 11/2022 - 11/2008
3	DiureticsIBA 01/2020 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 11/2022 - 11/2008
2	Spironolactone (Aldactone)FDA LinkGeneric 11/2022 - 11/2008
2	SodiumIBA 01/2020 - 01/2018
1	prothrombin fragment 1.2IBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2023
1	Thrombin FDA Link 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	Neprilysin (Neutral Endopeptidase)IBA 11/2022
1	Eplerenone (Inspra)FDA LinkGeneric 11/2022
1	DiamondIBA 11/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022
1	PotassiumIBA 11/2022
1	patiromerIBA 11/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Dobutamine FDA LinkGeneric 11/2021
1	Milrinone (Primacor)FDA LinkGeneric 11/2021
1	Anticoagulant Reversal AgentsIBA 09/2019
1	4-methyl-2,3-secocholestane-2,3-diolIBA 09/2019
1	recombinant FVIIa (rFVIIa)FDA Link 09/2019
1	Prothrombin (Factor II)IBA 09/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2019
1	Antihypertensive Agents (Antihypertensives)IBA 09/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2012
1	Bronchodilator Agents (Bronchodilators)IBA 05/2012
1	Baclofen FDA LinkGeneric 12/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2011
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2011
1	Bisoprolol (Concor)FDA LinkGeneric 10/2011
1	Carvedilol (Coreg)FDA LinkGeneric 10/2011
1	Anti-Infective Agents (Microbicides)IBA 02/2011
1	Investigational DrugsIBA 05/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2010
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	Simvastatin (Zocor)FDA LinkGeneric 07/2009
1	Hydralazine (Apresoline)FDA LinkGeneric 11/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2008
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 11/2008
1	Prostaglandins AIBA 11/2007

Therapy/Procedure

16	Therapeutics 12/2022 - 11/2008
7	Heart-Assist Devices 01/2023 - 04/2004
5	Heart Transplantation (Grafting, Heart) 01/2022 - 11/2018
4	Transplantation 11/2021 - 05/2011
2	Extracorporeal Membrane Oxygenation 11/2023 - 01/2022
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2010 - 08/2009
1	Cannula 11/2023
1	Continuous Renal Replacement Therapy 09/2021
1	Length of Stay 01/2020
1	Cardiac Resynchronization Therapy 09/2012
1	Drug Therapy (Chemotherapy) 12/2011
1	Liver Transplantation 06/2008
1	Denervation 03/2005